If employees work with hazardous substances, it can be difficult to know whether your exposure controls are working as intended in day-to-day conditions.
Biological monitoring provides an additional way to assess exposure by measuring a substance, or its breakdown products, in samples such as urine or blood. This can help you understand what has actually been absorbed through all routes of exposure—including inhalation, skin contact and accidental ingestion.
Clarity helps employers design practical biological-monitoring programmes around their processes, workforce roles and risk assessments. Whether you are reviewing controls, introducing a new chemical process or responding to an exposure concern, we will help you understand what is appropriate and how to manage it.
Biological monitoring is a form of exposure assessment. It measures a substance, or its metabolites, in a biological sample such as urine, blood or, in some cases, breath.
Unlike air monitoring alone, it can provide information about the amount of a substance that has entered the body through all relevant routes of exposure. This can be particularly useful where skin absorption is possible, respiratory protective equipment is used, exposure varies between tasks, or workers move between different areas of a site.
Biological monitoring can sit alongside air monitoring, workplace exposure assessment, health surveillance and risk assessment. It does not replace the need to eliminate or control hazardous-substance exposure at source.
Where results indicate a level of exposure that requires further attention, this should prompt a review of engineering controls, respiratory protective equipment, personal protective equipment, work practices, training and supervision. It is not about blaming employees; it is about understanding how well controls work in real conditions.
We design biological-monitoring programmes around your actual processes, substances, exposure scenarios and workforce roles—not generic testing timetables. We help you identify who should be included, which biological marker may be relevant, when samples should be collected and how frequently monitoring may be useful. The timing of sampling is important because it must reflect the substance and exposure pattern being assessed.
We can plan biological monitoring around shifts, production schedules, site access and workforce availability. Sample collection may be arranged through on-site clinics, mobile medical units or suitable local appointments, depending on the substance, sample type and programme requirements. We provide clear instructions for employees and managers, including timing, collection, labelling, storage and transport requirements. Samples are coordinated for analysis by an appropriate laboratory.
Laboratory results can be technical. We provide clear interpretation and practical guidance, helping you understand what results may mean for your exposure controls and what should happen next. Reporting can help identify: Where results suggest that exposure controls are working effectively. Where lower-level exposure indicates that controls, PPE or work practices may need review. Patterns across tasks, teams, sites or processes that may help prioritise improvements.
Biological monitoring can sit alongside health surveillance, respiratory assessments, spirometry and other occupational health services. This can give you a more coordinated approach to managing chemical exposure and wider workforce health risk.
Biological monitoring may be appropriate for a range of workplace substances where a recognised biological marker and suitable sampling method are available.
Examples can include:
Isocyanates, used in paints, coatings, foams, resins and adhesives.
Certain solvents and organic chemicals, where biological markers can help assess absorption.
Metals and other agents with recognised biological indicators, including lead where the applicable regulatory requirements are met.
Other substances where biological monitoring is recommended by HSE guidance, industry standards or an occupational-hygiene assessment.
The most appropriate approach depends on the substance, task, exposure route, timing of exposure and available biological guidance values. We will help you understand whether monitoring is suitable for your specific processes.
Isocyanates are widely used in products such as two-pack paints, coatings, foams, resins, adhesives and some spray-applied materials. They are also a leading cause of occupational asthma in the UK.
Even where extraction, enclosure and respiratory protective equipment are in place, real-world exposure can still occur through skin contact, poor equipment fit, inconsistent use, inadequate maintenance or unexpected work practices.
For isocyanates, biological monitoring usually involves analysing a urine sample for relevant breakdown products. HSE advises that samples should be collected at the end of a period of potential exposure—normally within one hour—and that sampling should reflect normal working practice.
Results should be interpreted in the context of the work undertaken, the sample timing and the applicable guidance values. A result above a biological monitoring guidance value is not, by itself, a diagnosis of illness or proof of harm. It is a signal to investigate whether workplace controls are adequately limiting exposure.
A typical biological-monitoring programme involves:
We review the relevant substance, workplace process, exposure routes, roles and risk information. Together, we agree who will be included, what sample type is required, when samples should be taken and the appropriate monitoring frequency.
Planning – We review the relevant substance, workplace process, exposure routes, roles and risk information. Together, we agree who will be included, what sample type is required, when samples should be taken and the appropriate monitoring frequency.
Sample collection – Samples are collected at a time that reflects the substance and potential exposure. Depending on the programme, this may involve urine, blood or another appropriate sample. Employees receive clear information about the purpose of monitoring and what is involved.
Laboratory analysis – Samples are securely prepared and sent to an appropriate laboratory for analysis of the agreed substance or biological marker.
Interpretation and follow‑up – We help you interpret the results in the context of your workplace. Where results suggest a need for action, we can support a review of controls, work practices, PPE, training, supervision or further monitoring.
The aim is to give you objective feedback on how well exposure controls work in real life—not to catch employees out.
Biological-monitoring results can help you:
Check whether exposure is being controlled effectively across real working conditions.
Identify tasks, teams or situations where substance uptake may be higher.
Review whether respiratory protective equipment, gloves, ventilation or other controls are effective.
Prioritise improvements to training, engineering controls, work practices and supervision.
Support discussions with health and safety teams, occupational hygienists, employee representatives and senior leaders.
Demonstrate that you are actively checking whether workplace controls are protecting employees in practice.
Results should always be considered as part of the wider exposure-control picture, alongside risk assessment, air monitoring where relevant and workplace observations.
Whether you are reviewing chemical controls, introducing a new process, supporting high-risk roles or investigating an exposure concern, Clarity can help you develop a biological-monitoring programme that is proportionate, practical and built around your organisation.
We will take time to understand your substances, processes, workforce and operational needs, then help you put the right monitoring and follow-up arrangements in place.
Biological monitoring measures a chemical or its breakdown products in a biological sample, usually urine or blood, to indicate how much of a substance may have entered a worker’s body through relevant exposure routes. It is used to help assess workplace exposure and the effectiveness of control measures.
It may be used where workers could absorb certain hazardous substances through inhalation, skin contact or accidental ingestion, and where a suitable biological marker and sampling method are available. Examples can include isocyanates, selected solvents, certain metals and other substances with recognised biological indicators.
For many substances, biological monitoring is not a general statutory requirement and is used as an exposure-management tool. However, specific legal requirements apply in some circumstances, including lead exposure under the Control of Lead at Work Regulations 2002. The correct approach depends on the substance, work activity, exposure level and applicable regulations.
A programme usually involves planning around the relevant substance and work tasks, collecting samples at the appropriate time, laboratory analysis, and interpretation of results alongside your risk assessment and exposure controls. Depending on the substance, samples may include urine, blood or another appropriate biological sample.
Results can provide insight into whether substances may be entering workers’ bodies despite existing controls. This can help employers review ventilation, PPE, gloves, respiratory protection, work practices, training and supervision. Results should be interpreted alongside other exposure information and do not, by themselves, diagnose illness.
The appropriate frequency depends on the substance, biological marker, exposure pattern, risk assessment and purpose of the programme. For isocyanates, HSE advises that sample timing should reflect normal work and be taken at the end of potential exposure; your monitoring plan should be designed around the specific process and control measures.
Clarity can support the planning of a biological-monitoring programme, arrange suitable sample-collection options, coordinate laboratory analysis and provide clear, actionable reporting. Delivery may include on-site clinics, mobile medical units or local clinic appointments, depending on the requirements of the programme.
Biological monitoring programmes should be delivered with clear information, appropriate consent, confidentiality and secure handling of health information. Employees should understand the purpose of monitoring, how samples and results will be used, and what information may be shared with managers. Employers receive appropriate summary and workplace-action information rather than full confidential clinical records.
Tell us about your workforce, sites and requirements. We will call you to discuss a practical occupational health solution and the most suitable delivery options.
Tell us your workforce size, locations and main risks. We’ll recommend a practical delivery model and respond within one working day.
Telephone
Email